We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Discover PrEP (Pre-Exposure Prophylaxis), a daily medication that significantly reduces the risk of HIV infection. Learn how it works, who it's for, and what you need to know for effective use in India.

In the vibrant landscape of India, where life pulses with energy and connection, staying informed about health is paramount. Today, we're talking about a powerful tool in the fight against HIV: Pre-Exposure Prophylaxis, or PrEP. It's a daily medication that can dramatically reduce your risk of contracting HIV, offering peace of mind and empowering you to live your life to the fullest. Think of it as a daily shield, a proactive step you can take for your well-being and the well-being of your loved ones. While HIV has thankfully become less prevalent in many parts of the world, it remains a significant health concern globally, and India is no exception. Millions of people worldwide live with HIV, and a concerning number remain unaware of their status. PrEP offers a beacon of hope, especially for those who may be at a higher risk of exposure. This isn't about fear; it's about informed choices and taking control of your health journey. So, what exactly is PrEP? Simply put, it's a daily pill that you take before you are exposed to HIV. It contains antiviral medications that work by preventing the HIV virus from multiplying in your body if you come into contact with it. It's a game-changer, a scientific marvel that, when used correctly, can be incredibly effective. According to the Centers for Disease Control and Prevention (CDC), PrEP can reduce the risk of getting HIV from sex by about 99% and from injecting drug use by about 74%. That's a significant reduction, offering a substantial layer of protection. How Does PrEP Work Its Magic? The medications used in PrEP belong to a class of antivirals known as Nucleoside Reverse Transcriptase Inhibitors (NRTIs). These clever drugs work by targeting a specific enzyme that HIV needs to replicate itself. By blocking this enzyme, they essentially stop the virus in its tracks, preventing it from establishing a long-term infection in your body. It’s a sophisticated mechanism, but the result is straightforward: a dramatically lowered risk of HIV transmission. It's crucial to understand that PrEP is not a cure for HIV, nor is it a treatment for those already living with the virus. PrEP is strictly for individuals who do not have HIV but are at risk of contracting it. Taking PrEP when you already have HIV can lead to drug resistance, making future treatment less effective. This is why regular testing is a non-negotiable part of the PrEP regimen. Who Can Benefit from PrEP? PrEP is a powerful tool for anyone who is not living with HIV but is at a higher risk of contracting it. This includes: Individuals who have had anal or vaginal sex in the past 6 months and are not in a mutually monogamous relationship with a partner who is HIV-negative and taking PrEP. People who have recently had an STI (Sexually Transmitted Infection) in the past 6 months. Individuals who inject drugs and share needles or injection equipment. People who have been prescribed post-exposure prophylaxis (PEP) more than once in the past year. Your doctor will help you assess your individual risk and determine if PrEP is the right choice for you. It's a personalized approach to HIV prevention. The Approved PrEP Medications in India Currently, two main medications are approved by regulatory bodies for PrEP use. The choice between them often depends on individual health factors and doctor's recommendations: 1. Truvada (Emtricitabine/Tenofovir Disoproxil Fumarate) Truvada is one of the most widely used PrEP medications. It's available in tablet form and is taken once daily. It is approved for both men and women and is effective for preventing HIV acquisition through both sexual contact and injection drug use. For maximum protection, it needs to be taken consistently. 2. Descovy (Emtricitabine/Tenofovir Alafenamide) Descovy is another effective PrEP option. Like Truvada, it's a daily pill. However, Descovy has a different formulation of tenofovir, which may result in fewer side effects for some individuals, particularly concerning kidney and bone health. It's important to note that Descovy is approved for use in adults and adolescents weighing at least 35 kilograms (around 77 pounds). While effective for men and individuals engaging in receptive anal sex, Descovy is not currently approved for women at risk of HIV through vaginal sex because its effectiveness in this specific group has not been fully established through clinical trials. Your healthcare provider will discuss these options with you, considering your specific health profile and risk factors, to determine the best medication for your needs. Getting Started with PrEP: What to Expect Starting PrEP is a process, and your health and safety are the top priorities. Before you begin taking PrEP, and regularly thereafter, several steps are essential: HIV Testing: You must have a negative HIV test result before starting PrEP. This ensures that the medication is appropriate for you. STI Screening: Your doctor will likely screen you for other STIs, as untreated STIs can increase your risk of contracting HIV. Kidney and Liver Function Tests: These tests help ensure your organs can handle the medication. Hepatitis B and C Testing: These tests are also important, as some PrEP medications can affect these conditions. Once you start PrEP, regular follow-up appointments are critical. You'll need to see your doctor at least every 3 months for: HIV Re-testing: This is vital to ensure you remain HIV-negative. STI Re-screening: To monitor for any new infections. Prescription Refills: To ensure you never miss a dose. General Health Check-up: To monitor for any potential side effects. This consistent monitoring is what makes PrEP so effective. Missing appointments or doses can reduce its protective benefits. The Importance of Consistency and Adherence PrEP is a daily medication. The key to its effectiveness lies in taking it every single day as prescribed. While it offers significant protection, it doesn't work instantly. For maximum protection against HIV from anal sex, daily use for at least 7 days is recommended. For vaginal sex or injection drug use, it can take up to 21 days of consistent daily use to reach peak protection levels. Missing doses can leave you vulnerable. If you do miss a dose, talk to your doctor about the best way to get back on track. Potential Side Effects of PrEP Like all medications, PrEP can have side effects, though many people experience none or only mild ones. The most commonly reported side effects include: Nausea Headache Fatigue Diarrhea Stomach pain These symptoms often subside within the first few weeks of starting the medication. If side effects are bothersome or persistent, don't hesitate to discuss them with your doctor. They can help manage them or explore alternative options. Less common, but more serious side effects, can include effects on kidney and bone health, particularly with Truvada. Regular monitoring by your doctor helps detect and manage these issues promptly. PrEP vs. PEP: Understanding the Difference It's important to distinguish PrEP from Post-Exposure Prophylaxis (PEP). While both are HIV prevention strategies involving medication, they serve different purposes: PrEP (Pre-Exposure Prophylaxis): Taken daily by individuals who are HIV-negative but at high risk of exposure, to prevent HIV infection. PEP (Post-Exposure Prophylaxis): Taken after a potential exposure to HIV (e.g., unprotected sex, needle-stick injury) to prevent infection. PEP must be started as soon as possible, ideally within 72 hours of exposure, and is taken for 28 days. PrEP is a long-term prevention strategy, while PEP is an emergency measure. Living with HIV and PrEP If you are already living with HIV, PrEP is not the right medication for you. Treatment for HIV involves a different set of antiretroviral drugs designed to manage the virus and maintain your health. If you suspect you might have HIV or have been diagnosed, it is essential to consult a healthcare professional immediately for appropriate diagnosis and treatment. PrEP is about prevention, not treatment. When to Consult a Doctor Consult your doctor if you: Are considering PrEP and want to understand your risk factors. Have missed doses of your PrEP medication. Are experiencing side effects that concern you. Have been potentially exposed to HIV and need to know about PEP. Are sexually active and want to discuss comprehensive HIV prevention strategies. Your doctor is your best resource for personalized advice and care regarding HIV prevention and sexual health. Frequently Asked Questions (FAQs) Q1: Can PrEP protect me from other STIs? A: No, PrEP only protects against HIV. It does not prevent other sexually transmitted infections like chlamydia, gonorrhea, or syphilis. It's essential to continue practicing safer sex, including using condoms, and get regular STI testing. Q2: Is PrEP available in India? A: Yes, PrEP medications are available in India, and they are prescribed by doctors. Access and cost can vary, so it's best to discuss this with your healthcare provider. Q3: How long do I need to take PrEP? A: The duration of PrEP use is highly individualized. It depends on your ongoing risk of HIV exposure. Some people take it for a short period, while others may need to take it long-term. Your doctor will
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and what results mean for patients.
April 20, 2026

Discover how specialized staining techniques, like Giemsa, are crucial for accurately diagnosing Leishmaniasis, identifying the parasite, and guiding timely treatment. Understand this key diagnostic approach.
April 20, 2026

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and why it's a vital tool in combating this disease.
April 20, 2026